ALINA: efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK plus non-small cell lung cancer (NSCLC)

被引：0

作者：

Shah, Rajiv ^{[1
,2
]}

Solomon, Benjamin J. ^{[3
]}

Ahn, Jin Seok ^{[4
]}

Dziadziuszko, Rafal ^{[5
,6
]}

Barlesi, Fabrice ^{[7
]}

Nishio, Makoto ^{[8
]}

Lee, Dae Ho ^{[9
]}

Lee, Jong-Seok ^{[10
]}

Zhong, Wenzhao ^{[11
]}

Horinouchi, Hidehito ^{[12
]}

Mao, Weimin ^{[13
]}

Hochmair, Maximilian ^{[14
]}

de Marinis, Filippo ^{[15
]}

Migliorino, Maria Rita ^{[16
]}

Bondarenko, Igor ^{[17
]}

Lohmann, Tania Ochi ^{[18
]}

Xu, Tingting ^{[19
]}

Cardona, Andres ^{[20
]}

Bordogna, Walter ^{[21
]}

Ruf, Thorsten ^{[22
]}

Wu, Yi-Long ^{[11
]}

机构：

[1] Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany

[2] NCT Heidelberg, Translat Lung Res Ctr Heidelberg TLRC H, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Australia

[4] Samsung Med Ctr, Dept Hematol & Oncol, Seoul, South Korea

[5] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[6] Med Univ Gdansk, Early Phase Clin Trials Ctr, Gdansk, Poland

[7] Saclay Univ, Dept Med Oncol, Int Ctr Thorac Canc CICT, Gustave Roussy,Fac Med, Le Kremlin Bicetre, France

[8] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[9] Asan Med Ctr, Dept Oncol, Seoul, South Korea

[10] Seoul Natl Univ, Div Hematol & Med Oncol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea

[11] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangzhou, Peoples R China

[12] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan

[13] Chinese Acad Sci, Inst Basic Med & Canc, Hangzhou, Zhejiang, Peoples R China

[14] Klin Floridsdorf, Dept Resp & Crit Care Med, Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria

[15] European Inst Oncol IRCSS, Thorac Oncol Div, Milan, Italy

[16] San Camillo Forlanini Hosp, Pneumooncol Unit, Rome, Italy

[17] Dnipropetrovsk Med Acad, Oncol & Med Radiol Dept, Dnipro, Ukraine

[18] F Hoffmann La Roche Ltd, PD Oncol, Basel, Switzerland

[19] Roche China Holding Ltd, Dept Clin Sci, Shanghai, Peoples R China

[20] F Hoffmann La Roche Ltd, Data & Stat Sci, Basel, Switzerland

[21] F Hoffmann La Roche Ltd, Prod Dev Med Affairs, Basel, Switzerland

[22] F Hoffmann La Roche Ltd, PD Safety Risk Management, Basel, Switzerland

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1018

引用

页码：243 / 244

页数：2

共 50 条

[41] Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer
Yu, Hui
Sun, Si
Hu, Xingjiang
Xia, Jinjing
Wang, Jialei
Chen, Haiquan
ONCOTARGETS AND THERAPY, 2019, 12 : 6481 - 6495
[42] CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS OF PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
Flores-Caballero, M. A.
Lugo-Martinez, G.
Rodriguez-Cid, J. R.
Juarez-Vignon Whaley, J.
Cruz-Zermeno, M.
Seidman-Sorsby, A.
Martinez-Herrera, F.
Garcia-Montes, V
Garibay-Diaz, J. C.
Espinosa, Gonzalez, I
Hernandez-Flores, O.
Oyervides-Juarez, V. M.
Gonzalez-Cisneros, P.
Sala, Riera R.
Alatorre-Alexander, J.
Betancur, M. A.
Medina, S.
Rojowska, A.
Lopez Lopez, F.
VALUE IN HEALTH, 2023, 26 (12) : S217 - S217
[43] Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer
Belen Custodio, Ana
Luis Gonzalez-Larriba, Jose
Bobokova, Jana
Calles, Antonio
Alvarez, Rafael
Cuadrado, Eugenio
Manzano, Aranzazu
Diaz-Rubio, Eduardo
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (07) : 891 - 910
[44] Alectinib impressively enters the adjuvant setting for early-stage ALK-rearranged non-small cell lung cancer and outperforms chemotherapy-let's define who benefits the most
Santoni-Rugiu, Eric
Sorensen, Jens Benn
Urbanska, Edyta Maria
TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (02) : 310 - 313
[45] Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer
Streit, Arthur
Lampridis, Savvas
Seitlinger, Joseph
Renaud, Stephane
Routledge, Tom
Bille, Andrea
CURRENT ONCOLOGY REPORTS, 2024, 26 (01) : 55 - 64
[46] Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer
Arthur Streit
Savvas Lampridis
Joseph Seitlinger
Stéphane Renaud
Tom Routledge
Andrea Bille
Current Oncology Reports, 2024, 26 : 55 - 64
[47] Survival of Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) Diagnosed at a Safety-Net Hospital (SNH)
Reddy, Priyanka
Derton, Abigail
Teigen, Kari
Jensen, Carissa
Johnson, Raymond
Ghabach, Bassam
Narra, Kalyani
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E59 - E60
[48] Segmentectomy versus lobectomy in younger patients with early-stage non-small cell lung cancer
Kamigaichi, Atsushi
Mimae, Takahiro
Tsubokawa, Norifumi
Miyata, Yoshihiro
Kudo, Yujin
Nagashima, Takuya
Ito, Hiroyuki
Ikeda, Norihiko
Okada, Morihito
INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 2025, 40 (02):
[49] Patient and clinician perspectives on adjuvant treatment in early-stage non-small cell lung cancer (NSCLC): Qualitative results
Collacott, H.
Okhuoya, P.
Sandelin, M.
Michaels-Igbokwe, C.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S100 - S100
[50] Neo-adjuvant chemotherapy in early stage non-small cell lung cancer
Boukovinas, Ioannis
Tsakiridis, Kosmas
Zarogoulidis, Paul
Machairiotis, Nikolaos
Katsikogiannis, Nikolaos
Kougioumtzi, Ioanna
Zarogoulidis, Kostantinos
JOURNAL OF THORACIC DISEASE, 2013, 5 : S446 - S448

← 1 2 3 4 5 →